secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001654954-23-015713
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision reports H1 2023 revenue $181k, cash $7.4M; VIVO registry fully enrolled
--------------------------------------------------------------------------------

- Total revenue for six months ended June 30, 2023 was $181,000.
- Cash and cash equivalents $7.4 million; total assets $35.5 million at June 30, 2023.
- Completed enrollment of 125-patient VIVO registry; follow-up data expected June 2024.
- Initiated first LockeT study (100 patients) to demonstrate time to hemostasis and ambulation.
- Merger accounting between Ra Medical and Catheter Precision completed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495423015713/0001654954-23-015713-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495423015713/rmed_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-015713

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer